Susceptible and Protective Associations of HLA Alleles and Haplotypes with Cervical Cancer in South India

  • Rathika, Chinniah (Department of Immunology, School of Biological Sciences, Madurai Kamaraj University) ;
  • Murali, Vijayan (Department of Biotechnology and Genetic Engineering, Bharathidasan University) ;
  • Dhivakar, Mani (Department of Immunology, School of Biological Sciences, Madurai Kamaraj University) ;
  • Kamaraj, Raju (Department of Immunology, School of Biological Sciences, Madurai Kamaraj University) ;
  • Malini, Ravi Padma (Department of Immunology, School of Biological Sciences, Madurai Kamaraj University) ;
  • Ramgopal, Sivanadham (Department of Immunology, School of Biological Sciences, Madurai Kamaraj University) ;
  • Balakrishnan, Karuppiah (Department of Immunology, School of Biological Sciences, Madurai Kamaraj University)
  • Published : 2016.05.01


Background: Human leukocyte antigen (HLA) genes have been implicated in cervical cancer in several populations. Objectives: To study the predispositions of HLA alleles/haplotypes with cervical cancer. Materials and Methods: Clinically diagnosed and PAP smear confirmed cervical cancer patients (n 48) and age matched controls (n 47) were genotyped for HLA-A,-B,-DRB1* and DQB1* alleles by PCR-SSP methods. Results: The frequencies of alleles DRB1*04 (OR=2.57), DRB1*15 (OR=2.04), DQB1*0301 (OR=4.91), DQB1*0601 (OR=2.21), B*15 (OR=13.03) and B*07 (OR=6.23) were higher in cervical cancer patients than in the controls. The frequencies of alleles DRB1*10 (OR=0.22) and B*35 (OR=0.19) were decreased. Strong disease associations were observed for haplotypes DRB1*15-DQB1*0601 (OR=6.56; p< $3.5{\times}10^{-4}$), DRB1*14-DQB1*0501 (OR=6.51; p<0.039) and A*11-B*07 (OR=3.95; p<0.005). The reduced frequencies of haplotypes DRB1*10-DQB1*0501 (OR=0.45), A*03-B*35 (OR=0.25) and A*11-B*35 (OR= 0.06) among patients suggested a protective association. HLA-C* typing of 8 patients who possessed a unique three locus haplotype 'A*11-B*07-DRB1*04' (8/48; 16.66%; OR=6.51; p<0.039) revealed the presence of a four locus haplotype 'A*11-B*07-C*01-DRB1*04' in patients (4/8; 50%). Amino acid variation analysis of susceptible allele DQB1*0601 suggested 'tyrosine' at positions ${\beta}9$ and ${\beta}37$ and tyrosine-non-tyrosine genotype combination increased the risk of cervical cancer. Conclusions: Strong susceptible associations were documented for HLA alleles B*15, B*07, DRB1*04, DRB1*15, DQB1*0301, DQB1*0601 and haplotypes DRB1*15-DQB1*0601 and DRB1*14-DQB1*0501. Further, protective associations were evidenced for alleles B*35 and DRB1*10 and haplotypes A*11-B*35 and DRB1*10-DQB1*0501 with cervical cancer in South India.


Human leukocyte antigen;alleles/haplotypes;cervical cancer;susceptibility;protection;South India


Supported by : Madurai Kamaraj University


  1. Allen M, Kalantari M, Ylitalo N, et al (1996). HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indication of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens, 48, 32-37.
  2. Apple RJ, Becker TM, Wheeler CM, et al (1995). Comparison of human leukocyte antigen DR-DQ disease associations found with cervical displacia and invasive cervical carcinoma. J Natl Cancer Inst, 87, 427-36.
  3. Apple RJ, Erlich HA, Klitz W, et al (1994). HLA DR-DQ associations with cervical carcinoma show papillomavimrus-type specificity. Nature Genet, 6, 157-62.
  4. Baas A, Gao X, Chelvanayagam G (1990). Peptide binding motifs and specificities for HLA-DQ molecules. Immunogenetics, 50, 8-15.
  5. Balakrishnan K, Pitchappan RM, Suzuki K, et al (1996). HLA affinities of Iyers, a Brahmin population of Tamil Nadu, South India. Hum Biol, 68, 523-37.
  6. Balakrishnan K, Rathika C, Kamaraj R, et al (2012). Gradients in Distribution of HLA - DRB1* Alleles in Castes and Tribes of South India. Int J Hum Genet, 12, 45-55.
  7. Bhattacharya P, Sengupta S (2005). HLA DQB1*03 genotypes and susceptibility to cervical cancer in Indian Women. Int J Hum Genet, 5, 21-7.
  8. Brady CS, Bartholomeww JS, Burt DJ, et al (2000). Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens, 55, 401-11
  9. Bunce M, O'Neill CM, Barnardo MC, et al (1995). Phototyping: Comprehensive DNA typing for HLA A,B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primers mixes utilizing sequence specific primers (PCR-SSP). Tissue Antigens, 46, 355-67.
  10. Cervical cancer. Estimated incidence, mortality and prevalence worldwide in 2012. (Accessed on March 18, 2015).
  11. Chan PK, Cheung JL, Cheung TH, et al (2007). HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population. Gynecol Oncol, 105, 736-41.
  12. Chen D, Gyllensten U (2014). Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility. Carcinogenesis, 235, 1765-9.
  13. Cuzick J, Terry G, Ho L, et al (2000). Association between high-risk HPV types, HLA DRB1* and DQB1* alleles, and cervical cancer in British women. Br J Cancer, 82, 1348-52.
  14. Das BC, Hussain S, Nasare V, et al (2008). Prospects and Prejudices of human papilloma virus vaccines in India. Vaccines, 26, 2669-79.
  15. Dehaghani AS, Amirzargar A, Farjadian S (2002). HLA-DQB1 alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients. Pathol Oncol Res, 8, 58-61.
  16. Duggan-Keen MF, Keating PJ, Stevens FR et al (1996). Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression. Eur J Immunogenet, 23, 275-84.
  17. Evavold BD, Allen PM (1991). Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science, 252, 1308-10.
  18. Gokhale P, Kerkar S, Tongaonkar H, et al (2014a). Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women. Indian J Med Res, 140 (Supplement), 36-43
  19. Gokhale P, Mania-Pramanik J, Sonawani A et al (2014b). Cervical cancer in Indian women reveals contrasting association among common sub-family of HLA class I alleles. Immunogenetics Dec, 66, 683-91.
  20. Gregoire L, Lawrence WD, Kukuruga D (1994). Association between HLADQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer, 57, 504-7.
  21. Helland A, Olsen AO, Gjoen K, et al (1998). An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a populationbased case-control study of Norwegian women. Int J Cancer, 76, 19-24.<19::AID-IJC4>3.0.CO;2-0
  22. Hu JM, Sun Q, Li L, et al (2014). Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China. Int J Clin Exp Pathol, 15, 6165-71.
  23. Kohaar I, Hussain S, Thakur N, et al (2009). Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women. Hum Immunol, 70, 222-9.
  24. Kurl EJ, Schipper RF, Schreuder GM, et al (1999). HLA and susceptibility to cervical neoplasia. Hum Immunol, 60, 337-42.
  25. Lin P, Koutsky LA, Critchlow CW, et al (2001). HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev, 10, 1037-45.
  26. Matsumoto K, Maeda H, Oki A ,et al (2015). Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis? Cancer Sci, 106, 1448-54.
  27. Montoya L, Saiz I, Rey G, et al (1998). Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur J Immunogenet, 25, 329-337.
  28. Odunsi K Ganesan T (2001). Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis. International J Molecular Med, 8, 405-412.
  29. Odunsi K, Terry G, Ho L, et al (1995). Association between HLA DQB1*03 and cervical intra-epithelial neoplasia. Mol Med, 1, 161-171.
  30. Odunsi K, Terry G, Ho L, et al (1996). Susceptibility to human papillomavirus-associated cervical intr-epithelial neoplasia ia determined by specific HLA DR-DQ alleles. Int J Cancer, 67, 595-602.<595::AID-IJC1>3.0.CO;2-P
  31. Olerup O, Zetterquist H (1992). HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor matching in cadaveric transplantation. Tissue Antigens, 39, 225-35.
  32. Pingel J, Solloch UV, Hofmann JA, et al (2013). High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: How can they be used to improve unrelated donor searches? Human Immunol, 74, 330-40
  33. Pitchappan RM, Kakkanaiah VN, Rajashekar R, et al (1984). HLA antigens in south india. i. major groups of tamil nadu. Tissue Antigens, 24, 190-6.
  34. Rajasekar R, Kakkanaiah VN, Pitchappan RM (1987). HLA antigens in South India II: selected caste groups of Tamil Nadu. Tissue Antigens, 30, 113-8.
  35. Sanjeevi CB, Hjelmstrom P, Hallmans G, et al (1996). Different HLA DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swidish women. Int J Cancer, 68, 409-14.<409::AID-IJC1>3.0.CO;2-4
  36. Schiff MA, Apple RJ, Lin P, et al (2005). HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Hum Immunol, 66, 1050-6.
  37. Scola L, Lio D, Candore G, et al (2008). Analysis of HLA-DRB1, DQA1,DQB1 haplotypes in Sardinian centenarians. Exp Gerontol, 43, 114-8.
  38. Syrjanene K, Nurmi T, Mantyjacvi R, et al (1996). HLA types in women cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years. Cytopathol, 7, 99-107.
  39. Tonks S, Marsh SCE, Bunce M, et al (1999). Molecular typing for HLA classI using ARMS-PCR: Further developments following the 12th International Histocompatibility Workshop. Tissue Antigens, 53, 175-83.
  40. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.<12::AID-PATH431>3.0.CO;2-F
  41. Wang H, Qiao YL (2008). Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis. Int J STD AIDS, 19, 680-4
  42. Wang SS, Wheeler CM, Hildesheim A, et al (2001). Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis, 184, 1310-4.
  43. Wank R, Schendel DJ, Thomssen C (1992). HLA and cervical carcinoma. Nature, 356, 22-23.
  44. Wank R, Thomssen C (1991). High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature, 352, 723-5.
  45. Welsh KI, Bunce M. (1999). Molecular typing for the MHC with PCR-SSP. Rev Immunogenet, 1, 157-76.
  46. Wu Y, Chen Y, Li L, et al (2006). Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol, 35, 264-9.
  47. Yang YC, Chang TY, Lee YJ, et al (2006). HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis. Hum Immunol, 67, 331-40.
  48. Yang YC, Chang TY, Chen TC, et al (2015). Genetic susceptibility to cervical squamous cell carcinoma is associated with HLA-DPB1 polymorphisms in Taiwanese women. Cancer Immunol Immunother, 64, 1151-7
  49. Zhang X, Lv Z, Yu H, et al (2015). The HLA-DQB1 gene polymorphisms associated with cervical cancer risk: A meta-analysis. Biomed Pharmacother, 73, 58-64.

Cited by

  1. Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome vol.297, pp.3, 2018,